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Abstract
Treatment for chronic pain is frequently unsuccessful 
or characterized by side-effects. The high-frequency 
repetitive transcranial magnetic stimulation (HF-rTMS) 
has been suggested in the management of refractory 
chronic pain. Various studies have shown that HF-
rTMS sessions of long-duration applied at primary 
motor cortex induce pain relief through mechanisms of 
plastic changes. Efficacy of rTMS mostly depends on 
stimulation parameters, but this aspect requires better 
characterization. A rationale to target other cortical areas 
exists. Current data are promising, but a careful ana-
lysis of stimulation settings and maintenance treatment 
design are need. 
Key words: Transcranial magnetic stimulation; Repetitive 
transcranial magnetic stimulation; Neuropathic pain; 
Non-neuropathic pain; Chronic pain; Neuromodulation
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Core tip: The high-frequency repetitive transcranial 
magnetic stimulation (HF-rTMS) is emerging as a 
possible approach for pain relief. The HF-rTMS delivered 
to motor cortex modulates brain network implicated in 
pain processes, facilitating descending pain inhibitory 
mechainsms. Current data are promising, but a careful 
analysis of stimulation settings and maintenance treat-
ment design are necessary. 
Onesti E, Gori MC, Frasca V, Inghilleri M. Transcranial magnetic 
stimulation as a new tool to control pain perception. World J 
Anesthesiol 2016; 5(1): 15-27  Available from: URL: http://www.
wjgnet.com/2218-6182/full/v5/i1/15.htm  DOI: http://dx.doi.
org/10.5313/wja.v5.i1.15
INTRODUCTION
Chronic pain can be neuropathic, non-neuropathic, 
mixed, or without demonstrated origin[1]. Whilst acute 
pain is nociceptive secondary to chemical, mechanical 
and thermal stimulation of A-delta and C receptors, 
chronic neuropathic pain (NP) can persist after the initial 
injury because the nervous system is malfunctioning, 
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becoming the origin of the pain. Examples of NP are 
trigeminal neuralgia, postherpetic neuralgia, phantom 
limb pain, monoradiculopathies, complex regional pain 
syndromes and peripheral neuropathies. The prevalence 
of NP ranges from 7% to 8%[2-4]. The mechanisms 
involved in NP are complex and engage both periphe-
ral and central pathophysiologic events. Several NP 
research studies point to different causal mechanisms 
including neurogenic inflammation, abnormal ectopic 
activity in nociceptive nerves, and impaired inhibitory 
modulation, defining the so-called peripheral and central 
sensitization[5]. Available treatments provide mainly 
symptomatic relief, including nonpharmacological, 
pharmacological, and interventional therapies[6,7]. 
Unfortunately, the management of NP is not easy 
because the response to most drugs is not univocal[8,9]. 
According to recent guidelines, less than 50% of the 
patients with chronic NP reach symptomatic benefits 
with drugs[6,10,11].
In this setting, neurostimulation is a promising 
procedure in the treatment of pain[6,12]. The techniques 
suggested are: Transcutaneous electrical nerve stimu-
lation, nerve root stimulation, spinal cord stimulation, 
deep brain stimulation, transcranial direct current 
stimulation (tDCS), epidural motor cortex stimula-
tion, and repetitive transcranial magnetic stimulation 
(rTMS)[6]. 
Specifically, TMS was first introduced in the late 
1980s[13]. Initially, rTMS of the motor cortex was used 
to select patients for chronic stimulation by implanted 
electrodes[14]. It is a noninvasive method of stimulating 
cortical motor neurons through the scalp and skull 
capable of inducing electrical currents and depolarizing 
neurons in focal brain areas with the use of rapidly 
changing electromagnetic fields generated by a coil 
placed over the scalp[15-17]. Since then, several studies 
used rTMS as an investigational tool and a potential 
treatment for a variety of neurological and psychiatric 
disorders. Studies showed that rTMS provided at least 
partial and transient relief of chronic NP. When applied 
repetitively, trains of rTMS can modify cortical activity 
beyond the duration of the stimulation[18]. Three main 
aspects influence the effect of rTMS: Frequency, in-
tensity, and duration of stimulation. In general, bursts 
of high-frequency stimulation (≥ 5 Hz) lead to a facilit-
ation of activity in the targeted brain region, whereas 
continuous low-frequency stimulation (about 1 Hz) 
provides a suppression in activity of the targeted brain 
region. 
The rTMS produces analgesic effects activating 
fibres in the motor cortex and projecting to distant 
areas involved in pain processing[19,20]. In 2007, the 
EFNS produced the first guidelines on neurostimulation 
therapy for NP[6]. In recent years, new randomized 
controlled trials have published in various NP conditions. 
Therefore, we aimed to review all available evidence for 
TMS in neuropathic and non-NP, focusing the methods. 
A narrative synthesis was used to report the results. 
TMS AND CHRONIC PAIN TREATMENT
A search of literature on the analgesic effect of rTMS 
in chronic pain published from 1991 to May 2015 was 
performed using PubMed and the Cochrane Library. 
Keywords included chronic pain and neurostimulation, 
chronic pain and transcranial magnetic stimulation, NP 
and neurostimulation, NP and transcranial magnetic 
stimulation. The present review included controlled 
studies with at least 10 subjects enrolled to ensure 
the quality of the studies. Moreover, we excluded 
observational studies, and only papers in English were 
included. To minimize possible bias, the study selection-
process was carried out independently by two authors 
(EO, MI). 
We identified 38 controlled studies, including sham 
stimulations, in patients with NP (spinal cord lesions, 
central post-stroke pain-CPSP-, trigeminal nerve lesions, 
peripheral nerve lesions, phantom pain, fibromyalgia 
and complex regional pain syndrome type Ⅱ-CRPSII-) 
or non-NP (migraine, CRPS type Ⅰ, low back pain, 
visceral and postoperative pain). Table 1 summarizes 
these studies. The analysis included 983 patients. 
Among them, 31 studies showed significant pain redu-
ction with the high-frequency rTMS (HF-rTM) of the 
motor cortex (Table 1). 
Unfortunately, the studies currently available have 
been performed on groups of patients with different 
kinds of NP. Evidence at medium follow-up allowing solid 
conclusions to be drawn is insufficient and conflicting, 
while evidence at long follow-up is restricted. Future 
studies on a large number of patients with pain due to 
specific diseases and the evaluation of maintainance 
treatment cycles should provide more certain and 
reproducible data.
Efficacy of rTMS in NP
Efficacy of rTMS mostly depends on stimulation parame-
ters. When rTMS is applied in the primary motor cortex 
at low-frequency it is unsuccessful[21-23], while repea-
ted sessions of long-duration (at least 1000 pulses) 
stimulations at high-frequency (5-20 Hz) applied over 
repeated sessions induce pain relief[1,24-27]. RTMS seems 
most effective when stimulation is focal (i.e., figure-
of-eight rather than circular coil)[6]. The effect starts a 
few days later; its duration is less than a week after 
a single session, 2-3 wk after consecutive sessions 
of rTMS[28-30]. This last aspect is the keystone for the 
clinical benefit[31,32]. However, this feature requires 
better characterization[6]. The TMS parameters vary 
in the studies, and it is complex to establish the best 
stimulation parameters to use[12]. The role of coil 
orientation, time of train of stimulation, inter-train 
interval, and number of trains, is also to definite[12]. 
Moreover, 22 of the 32 studies had small sample 
sizes, with less than 30 enroled patients, and only 16 
of 32 studies recruited homogeneous populations of 
patients (CRPS, spinal cord injury, diabetic polyneuro-
pathy, poststroke pain and fybromialgia), reducing 
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Ref. Painful syndrome Study design Number of 
patients
Coil Site 
stimulation
Frequency, 
intensity, n  
sessions
Outcomes Efficacy
NP
Lefaucheur et 
al[26]
Intractable neurogenic 
pain
Double-blind, 
controlled, 
crossover
18 F8 Hand M1 0.5-10 Hz Pain intensity Analgesic 
effect (only for 
10 Hz)
(12 central NP; 6 
peripheral NP)
80% RMT
1
Lefaucheur et 
al[116]
Pain due to thalamic 
stroke or trigeminal 
neuropathy
Double-blind, 
controlled, 
crossover
14 F8 Hand M1 10 Hz VAS Decrease in 
VAS(7 central NP; 7 
peripheral NP)
80% RMT
1
Rollnik et al[41] Chronic refractory NP Double-blind, 
controlled, 
crossover
12 Double 
coin - 
Circular 
coin
M1 20 Hz VAS No effect
(2 central NP; 
7 peripheral 
NP; 2 CRPS; 1 
osteomyelitis)
80% RMT
1
Lefaucheur et 
al[27]
Pain do to thalamic 
stroke, brainstem 
stroke, spinal cord 
lesion, brachial plexus 
lesion, or trigeminal 
nerve lesion
Double-blind, 
controlled, 
crossover
60 F8 Hand M1 10 Hz VAS, thermal 
sensory 
thresholds
Analgesic 
effect mainly 
in trigeminal 
nerve lesions
(36 central NP; 24 
peripheral NP)
80% RMT
1
Khedr et al[25] Trigeminal neuralgia 
and post-stroke pain 
syndrome
Double-blind, 
controlled
48 F8 Hand M1 20 Hz VAS and the 
LANSS scale
Analgesic 
effect(24 central NP; 24 
trigeminal NP)
80% RMT
5
André-Obadia 
et al[22]
Chronic refractory NP Double-blind, 
controlled, 
crossover
14 F8 Hand M1 1-20 Hz VAS Analgesic 
effect (only for 
20 Hz)
(11 central NP; 3 
peripheral NP) 
90% RMT
1
Hirayama et 
al[104]
Intractable 
deafferentation pain
Double-blind, 
controlled, 
crossover
20 F8 M1 5 Hz VAS and SF-
MPQ
Analgesic 
effect(14 central NP; 6 
peripheral NP)
90% RMT
1
Irlbarcher et 
al[117]
Chronic NP Double-blind, 
controlled
27 F8 M1 1-5 Hz VAS No effect
(13 central NP; 14 
phantom p)
95% RMT
5
Lefaucheur et 
al[15]
Unilateral hand pain 
of various neurologic 
origins
Double-blind, 
controlled, 
crossover
22 F8 Hand M1 10 Hz Motor threshold 
at rest, MEP 
amplitude, CSP, 
ICI 
ICI increase
(14 central NP; 8 
peripheral NP)
90% RMT
1
Lefaucheur et 
al[118]
Chronic NP Double-blind, 
controlled, 
crossover
36 F8 Face M1 10 Hz VAS Analgesic 
effect with the 
stimulation 
applied on 
area adjacent 
to the cortical 
representation 
of the painful 
zone
80% RMT
1
Defrin et al[35] Spinal cord injury Double-blind, 
controlled
12 F8 Vertex 5 Hz VAS, MPQ, 
pain threshold
Increased heat 
pain threshold 115% RMT
10
Passard et al[29] Fibromyalgia Double-blind, 
controlled
30 F8 M1 10 Hz VAS, MPQ, 
quality of life 
(Brief Pain 
Inventory 
and the 
Fibromyalgia 
Impact 
Questionnaire)
Decrease in 
VAS and better 
quality of life
80% RMT
10
Saitoh et al[115] Intractable 
deafferentation pain
Double-blind, 
controlled, 
crossover
13 F8 M1 1-5-10 Hz VAS Decrease in 
VAS (only for 
5-10 Hz)
(9 central NP; 4 
peripheral NP)
90% RMT
1
André-Obadia 
et al[119]
Chronic NP Double-blind, 
randomized, 
controlled, 
crossover
28 F8 M1 20 Hz Pain relief, 
quality of life 
and rescue drug 
intake
Analgesic 
effect90% RMT
1
Table 1  Summary of the studies evaluating the effects of repetitive transcranial magnetic stimulation on chronic neuropathic pain 
and non-neuropathic pain
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Lefaucheur et 
al[120]
Chronic refractory NP Double-blind, 
controlled, 
crossover
46 F8 Hand M1 10 Hz Thresholds for 
thermal and 
mechanical 
sensations
Thermal 
perception 
improvement
(23 central NP; 23 
peripheral NP)
90% RMT
1
Carretero et 
al[121]
Fibromyalgia Randomized, 
single-blinded
28 Butterfly 
coil
DLPFC 1 Hz FibroFatigue, 
Likert pain, 
HDRS, CBI
No effect
110% RMT
20
Kang et al[36] Spinal cord injury Double-blind, 
controlled, 
crossover
11 F8 M1 10 Hz NRS, BPI No effect
80% RMT
5
Picarelli et al[33] CRPS type 1 Double-blind, 
controlled
23 F8 M1 10 Hz VAS, MPQ, the 
SF-36, HDRS
Analgesic 
effect and 
improved 
quality of life
90% RMT
10
Ahmed et al[108] Phantom pain Double-blind, 
controlled
27 F8 DLPFC 20 Hz VAS, LANSS 
scale
Decrease 
in VAS and 
LANSS scale
80% RMT
5
Mhalla et al[38] Fibromyalgia Double-blind, 
controlled
40 F8 M1 10 Hz Pain intensity 
over the last 24 
h, BPI, quality 
of life, mood 
and anxiety, 
parameters of 
motor cortical 
excitability
Analgesic 
effect80% RMT
Short et al[63] Fibromyalgia Double-blind, 
controlled
20 F8 M1 14 BPI, HDRS, 
Fibromyalgia 
Impact 
Questionnaire
Improvement 
of daily pain, 
number of 
tender points, 
HDRS and FIQ 
scores
10 Hz
120% RMT
Lefaucheur et 
al[122]
Chronic refractory NP Controlled, 
crossover
14 F8 M1 10 VAS Analgesic 
effect(3 localized in the 
face, 4 upper limb, 
3 lower limb, 4 
hemibody)
10 Hz
90% RMT
3
Hosomi et al[109] NP Double-blind, 
controlled, 
crossover
64 F8 M1 50 Hz VAS, SF-MPQ, 
PGIC, and BDI
Analgesic 
effect90% RMT
10
Onesti et al[28] Diabetic neuropathy Double-blind, 
controlled, 
crossover
23 H-coil Vertex 20 Hz VAS, area and 
threshold of 
RIII nociceptive 
flexion reflex 
RIII reflex
Decrease in 
VAS and RIII 
area
100% RMT
5
Jetté et al[34] Spinal cord injury Randomized, 
controlled, 
crossover
16 F8 M1 10 Hz VAS, motor 
mapping 
parameters
Decrease in 
VAS90%-110% 
RMT
3
Boyer et al[30] Fibromyalgia Double-blind, 
randomized, 
controlled
38 F8 M1 10 Hz FIQ, SF-36, 
brain 
metabolism
Improvement 
of quality of 
life
90% RMT
14
Dall’Agnol et 
al[123]
Myofascial pain 
syndrome
Double-blind, 
randomized, 
controlled
24 F8 M1 10 Hz Pain 
quantitative 
sensory testing, 
conditioned 
pain 
modulation, 
TMS 
parameters, 
BDNF
Analgesic 
effect 
mediated by 
mechanisms 
enhancing the 
corticospinal 
inhibitory 
system and 
BDNF
80% RMT
10
Yılmaz et al[40] Spinal cord injury Double-blind, 
randomized, 
controlled
17 F8 Vertex 10 Hz VAS No effect
110% RMT
10
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assurance about which states are more responsive to 
TMS[1,28-30,33-41]. Another unsolved question concerns 
which site in the motor cortex gives the most effective 
pain relief. Stimulation is commonly delivered to the 
contralateral motor cortex to painful area[1,42].
Also the left DLPFC could have a function in nocice-
ptive control, while the left prefrontal cortex has been 
used in rTMS studies in patients with fibromialgia[39,43] 
(Figure 1). 
Also tDCS, a technique that elicits constant weak 
electric currents through the scalp throught two 
electrodes, is able to modulate excitability in cortical 
tissue. Moreover, it is important to specify that tDCS 
does not induce action potentials in axons, but it cause 
polarization of neurons changing their average level of 
discharge. Several studies examined the tDCS applied 
to the motor cortex as a possible treatment of chronic 
pain, but a recent meta-analysis does not suggest a 
significant analgesic effect of this technique[23]. 
The mechanisms underlying the effect of rTMS in 
pain are not clearly identified, but probably involve 
neuronal plasticity[44,45]. Therefore it is suggested that 
maintenance therapy for longer intervals should prolong 
long-lasting effects. Unfortunately, only one study to 
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Hodaj et al[124] Chronic refractory 
facial pain
Open-label study 55 F8 Face M1 10 Hz VAS, CGIC 
scale
Analgesic 
effect80% RMT
(19 cluster 
headache; 21 
trigeminal 
neuropathic pain; 
15 atypical facial 
pain)
12
Khedr et al[125] Malignant NP Randomized, 
controlled
34 F8 Hand M1 20 Hz VDS, VAS, 
LANSS, HDRS
Analgesic 
effect80% RMT
10
Lindholm et 
al[126]
Neuropathic orofacial 
pain
Randomized, 
controlled, cross-
over 
16 - S1/M1, right 
SII
- NRS, BPI Analgesic 
effect (only for 
SII)
Non-NP
Brighina et al[46] Migraine Double-blind, 
randomized, 
controlled
11 F8 DLPFC 10 Hz Frequency 
of attacks, 
Headache index
Significant 
reduction 
of outcome 
measures
90% RMT
12
Pleger et al[48] CRPS Double-blind, 
controlled, 
crossover
10 F8 M1 10 Hz VAS Analgesic 
effect110% RMT
1
Borckardt et 
al[127]
Postoperative pain Double-blind, 
controlled
20 F8 Left PFC 10 Hz VAS for mood, 
opioid pump 
use
Reduction in 
opioid use100% RMT
1
Johnson et al[49] Low back pain Double-blind, 
controlled, 
crossover
17 F8 M1 20 Hz Detection and 
pain thresholds 
for cold and 
heat sensations
Increased heat 
pain threshold 
and lowered 
cold detection
95% RMT
1
Fregni et al[50] Pancreatitis Double-blind, 
controlled
17 F8 SII 1 Hz VAS, BDI Analgesic 
effect70% RMT
10
-
Conforto et al[47] Migraine Randomized, 
double-blind, 
parallel-group
18 - DLPFC Number of 
headache days
No effect
Melchior et al[51] Irritable bowel 
syndrome
Double-blind, 
controlled, 
crossover
21 F8 M1 20 Hz Pressure pain 
threshold, 
changes in 
maximum 
tolerated rectal 
volume, rectal 
compliance and 
average pain 
intensity
Maximun 
tolerated 
rectal volume 
and analgesic 
effects
80% RMT
5
Avery et al[52] Chronic widespread 
pain
Double-blind, 
randomized, 
controlled
19 - DLPFC - BIRS No effect
15
NP: Neuropathic pain; BPI: Brief pain inventory; FIQ: Fibromyalgia impact questionnaire; F8: Figure of 8 coil; H: Hesed; HDRS: Hamilton depression rating 
scale; ICI: Intracortical inhibition; LANSS: Leeds assessment of neuropathic symptoms and signs; MPQ: McGill pain questionnaire; PFC: Prefrontal cortex; 
RIII: Nociceptive flexion reflex; SF-36: 36-item short-form health survey; SICI: Short intracortical inhibition; SII: Somatosensory cortex; VAS: Visual analog 
scale; MEP: Motor evoked potential; NRS: Numeric rating scale; PGIC: Patient global impression of change scale; BDNF: Brain-derived neurotrophic factor; 
VDS: Verbal descriptor scale; CGIC: Clinical global impression of change; DLPFC: Dorsolateral prefrontal cortex; BIRS: Gracely box intensity scale.
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date evaluated long-term rTMS maintenance therapy[38].
Efficacy of rTMS in non-NP
In the past ten years, the rTMS have been also eva-
luated in different non-NP conditions[1] (Table 1). 
Regarding application for migraine, active HF-rTMS 
delivered over the left DLPFC gave promising results 
but, in the absence of large controlled studies, no 
recommendation can be suggested[1,46,47]. Also regarding 
to the treatment of chronic visceral pain, low back pain 
and CRPS type Ⅰ with rTMS, literature is still limited, 
and no conclusion can be definitely drawn[48-52]. Future 
research in this field should specifically investigate in a 
large number of patients the most appropriate cortical 
target, and the frequency of stimulation[1]. Moreover, 
a specific analysis regarding to the possible effect of 
rTMS on other clinical aspects of these syndromes, such 
as affective-emotional and cognitive components is 
needed. 
PHYSIOLOGICAL BASIS OF rTMS
Practical aspects of rTMS
In 1985 Barker et al[13] proposed the first magnetic 
stimulator for the transcranial stimulation of the human 
brain, giving the prerequisite for subsequent clinical use 
of TMS. A stimulating coil produces a brief magnetic 
field when an electrical pulse generator creates a dis-
charge current of several thousand amperes. When 
the coil is placed on the skull of a subject, it induces 
an electrical field able to depolarize nerve cells and to 
stimulate neural networks[1]. The stimulus waveform 
can be monophasic or biphasic[53]. The rTMS using mono-
phasic pulses activates an homogeneous population of 
neurons, while biphasic pulses tend to generate a more 
complex pattern of neural activation, producing local 
changes but also effects at distance from the stimulus 
site[1,54]. 
Site of stimulation
The first task for pain modulation is to locate primary 
motor cortex (M1), checking visually the muscle 
twitch inducing by TMS pulses[12]. Commonly in clinical 
settings, the intensity of the TMS should be not able to 
induce a motor response[12]. Specifically, TMS applied 
in short trains at high frequency and suprathreshold 
intensity over the M1 elicits a progressive increase in 
motor evoked potential (MEP) amplitude, demonstrating 
the phenomenon of MEP amplitude facilitation, through 
intracortical mechanisms similar to short-term synaptic 
plasticity[55-59]. 
However, a rationale for targeting other cortical 
areas exists. The DLPFC could have a role in nociceptive 
control[43]. In healthy subjects with pain induced by a 
capsaicin injection into their hand, the stimulation of 
the left DLPFC produced a significant pain relief. No 
improvement was noted when the right DLPFC was 
stimulated[60]. The effect may be related to the release 
of endogenous opioids by the left DLPFC[61]. Also rTMS 
of the cerebellum has been considered for the possible 
lowering in pain thresholds[62]. Moreover, The left 
prefrontal cortex has been used in rTMS fibromyalgia 
studies, but only a small analgesic effect has been 
noted[63].
Intensity of stimulation
The intensity of the stimulation is classically regulated 
for each patient to obtain the minimal intensity of 
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DFLFC
   Left hemisphere
   Low-high frequency
   Possible efficacy in chronic NP and non-NP
DFLFC
   Right hemisphere
   Low-high frequency
   Possible efficacy in chronic NP and fibromyalgia
Primary somatosensory cortex
   Controlateral to pain
   High frequency
   Possible inefficacy in chronic NP
Secondary somatosensory cortex
   Right hemisphere
   Low frequency
   Possible efficacy in chronic visceral pain
Primary motor cortex
   Controlateral to pain
   Low frequency
   Inefficacy proved in chronic NP
Primary motor cortex
   Controlateral to pain
   High frequency
   Efficacy proved in chronic NP
   Possible efficacy in fibromyalgia and CRPS
Figure 1  Analgesic efficacy of repetitive transcranial magnetic stimulation according to the cortical target. DLPFC: Dorsolateral prefrontal cortex; NP: 
Neuropathic pain; CRPS: Complex regional pain syndrome.
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stimulation applied to M1 that evokes a motor response. 
It is measured according to the RMT, the lowest 
stimulation intensity able to generate a MEP small (50 
mV) amplitude in 5 of 10 TMS pulses. In the clinical 
setting, stimulation intensity is frequently subthreshold 
(80%-90% of RMT)[64]. When the RMT is identified, 
rTMS is performed in bursts of stimuli (“trains”) with a 
definite frequency[12]. 
Frequency of stimulation
RTMS can be carried out at low (1 Hz) or high frequen-
cies (5 Hz). When performed at high frequencies, 
rTMS pulses are delivered in trains divided by specific 
intertrain intervals. Typically, low-frequency rTMS is 
considered to have inhibitory properties, whereas HF-
rTMS is considered to have excitatory properties[64]. 
HF-rTMS consists specifically of intermittent bursts of 
TMS pulses able to induce a long-term potentiation of 
synaptic activiy, which may clarify why rTMS effects can 
overcome the period of stimulation[64]. 
Number of sessions and total number of pulses per 
session 
A central question is whether the analgesic effect 
of rTMS can be prolonged by maintenance sessions 
performed periodically. To date, 24 of 39 studies have 
performed repetitive sessions of rTMS to enhance 
analgesic effects of a single session of stimulation, but 
maintenance protocol was only tested in one study[38]. 
Usually, the number of sessions applied range from 5 
sessions to 30 sessions. The majority of studies have 
involved a total of 10 sessions. Based on more recent 
studies, a general trend indicates a greater number 
of sessions (> 10) associated with more persisting 
improvement in pain perception (Table 1). 
The total number of pulses in each rTMS session 
seems related to the analgesic effect, but it is not clear 
whether a minimum number of pulses is required to 
obtain the clinical outcome. Usually this value ranges 
between 1000 to 2000[1]. Moreover an important safety 
parameter as the intertrain interval (the time in bet-
ween trains of pulsed energy when no stimulation is 
occurring) is usually about 10 s[1].
Coil 
Coil design and orientation are important. The “figure-
of-eight” coil is able to induce a focal magnetic field 
stimulating only superficial cortical regions of the 
brain[12]. Other novel models are the Tilted double-
coil and the Hesed (H)-coil, which drop at a depth of 
about 6 cm[12]. Specifically, the H-coil lets deep brain 
stimulation without significantly increasing induced 
fields in superficial cortical regions, therefore preventing 
the risk of adverse effects[65,66]. rTMS with the H-coil 
has already proved effective as an acute treatment 
for major depressive disorder, bipolar depression, 
schizophrenia and post-traumatic stress disorder[65,67-69]. 
Furthermore, there are ongoing studies of its use to 
treat a very wide range of neurological, psychiatric and 
medical conditions, including NP[28].
Placebo rTMS
Placebo effects need to be better reported[25]. Theori-
cally, ideal placebo rTMS should be characterized by 
the same subjective somatic scalp sensation and 
the acoustic artifacts compared to active coil, and no 
physiological effect on the targeted cortical region[70]. 
In the early research, placebo was considered a coil 
placed in a different area from zone stimulated in the 
active condition, or a coil oriented with an angle of 
45-90 grades on the scalp instead of tangentially[1]. 
These solutions are not the most reliable, because the 
stimulation site could be perceived by the subject, or 
the sham location could cause unexpected effects[1,71]. 
In the last decades, sham coils have been projected 
and commercialized in order to block the magnetic field 
provided, and to produce auditory artifacts and scalp 
sensation equivalent to that of a real coil[72,73]. Although 
this stimulation ideally seems a perfect placebo, the 
cutaneous sensation remains different in about half of 
the cases, especially when the stimulation intensity is 
high[72,74].
CONSIDERATIONS ABOUT MECHANISMS 
OF ACTION OF rTMS
Although the TMS acts on the superficial cortex, the 
generated action potentials propagate influencing 
distant neural networks[12]. The M1 contains pyramidal 
cells that give rise to numerous excitatory corticospinal 
projections. Most of These projections are oriented 
perpendicularly to the brain surface. rTMS applycated 
on the M1 modulate the cortical excitability producing 
changes in the following physiological parameters: 
MT, MEP, silent period, intracortical facilitation, and 
intracortical inhibition[75]. In chronic pain, the involve-
ment of M1 projections to pain-modulating structures 
has been demonstrated[23]. Moreover, a rationale for 
targeting other cortical areas exists. The DLPFC is a 
cortical target used in studies on major depression, and 
it is considered to have a function also in nociceptive 
control[43,61,76]. HF-rTMS on the right DLPFC has 
shown analgesic effects similar to M1 stimulation[46,77]. 
Furthermore, left DLPFC stimulation should induce an 
improvement of pain perception in a model of acute 
pain[43,78]. The left prefrontal cortex has been used in 
rTMS studies in patients with fibromyalgia, but it has 
shown a minor analgesic effect[63].
rTMS seems to modulate cortical plasticity, referred 
to as the functional reorganization of the inter neuron 
connections and neuronal properties. Inhibition of 
the gamma-amminobutyric acid (GABA) pathways 
produces cortical excitation, rather than a direct enhan-
cement of motor cortex excitability[79-82]. On the other 
hand, low-frequency rTMS could increase the inhibi-
tory corticospinal control, perhaps through GABA-B 
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transmission, prolonging the CSP duration[1,83-86]. The 
changes in synaptic plasticity brought by rTMS are 
explained by long term potentiation (LTP) and long term 
depression (LTD)[44]. LTP is induced by high frequency 
stimulation and LTD by low frequency stimulation. 
The LTP is mediated by the post-synaptic N-methyl-
D-aspartate (NMDA) receptors, that lead to calcium 
flux into the post-synaptic neuron when activated[45]. 
Calcium activates enzymatic changes in pre- and post-
synaptic neurons, increasing the synaptic activity. It 
also induces the expression of alpha-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptors on 
the postsynaptic neuron, increasing the cells sensitivity 
to glutamate[87]. Furthermore, LTD is characterized by 
depression of the synaptic transmission, depending on 
the modulation of NMDA receptors with the reduction of 
calcium influx, and the internalization of AMPA[87].
The long lasting effect of rTMS (late-LTP) is thought 
to be exercised by gene induction and protein synt-
hesis[87]. Gene expression has resulted in increased 
synthesis of c-fos mRNA in the thalamus and parietal 
cortex, and BDNF mRNA in the hippocampus and 
parietal cortex[88-90]. Considerable evidence from HF-
rTMS studies suggests that short-term synaptic plasticity 
happens at cortical rather than spinal level[91-94]. When 
rTMS is delivered in human subjects, the amplitude of 
the MEP and the duration of the CSP increases during 
the train[55,75,95-100]. The MEP facilitation also persists after 
the train ends, and it is probably due to the recruitment 
of cortical excitatory interneurons[55,75,92,94,99]. It is 
influenced by the number of stimuli in the train, being 
greater with longer (20, 40 and 60-stimuli), suggesting 
mechanisms of short-term synaptic enhancement[59,101]. 
rTMS has also been found to modulate the acti-
vity of brain neurotransmitters, reducing dopamine 
in the frontal cortex and increasing its levels in the 
striatum[102]. Moreover, serotonin levels increased in the 
hippocampus[102]. All these aspects may explain why 
different rTMS protocols are effective or not, depending 
on various parameters of stimulation. Further, age, and 
genetic features could influence the clinical effect of 
rTMS, with heterogeneous therapeutic responses[1,103].
LIMITATIONS OF rTMS IN PAIN 
TREATMENT
The results of studies exploring the effects of rTMS 
on pain are positive but still inconsistent, because 
of small samples of patients, differences in the TMS 
methodologies, heterogeneous populations of patients 
and lack of maintenance protocols. In a Cochrane 
Review of 2013, a short-term effect on pain of HF-rTMS 
applied to M1 was confirmed[23]. Moreover, a detailed 
study to determine which are the best stimulation 
parameters, is targeted. Studies on image-guided 
navigation to perform rTMS of M1 in pain patients have 
provided evidence that the analgesic effect of rTMS links 
with the integrity of the thalamocortical tract[1,104,105]. 
Unfortunately, objective indicators of perceived pain, 
including MEP and RIII, were considered in only two 
studies neurophysiological[15,28]. New extended studies 
should improve knowledge in this field of research.
Further rigorously designed studies, particularly of 
longer courses of stimulation applied on large population 
of patients, are required to address the issue. Future 
evidence may significantly confirm the current results. 
The main question is whether the clinical effect could 
indeed improve the management of patients with 
chronic pain in daily clinical practice. 
FUTURE RESEARCH DIRECTIONS
The conclusions of our analysis, related to the actual 
literature data on rTMS for chronic pain, match with 
those suggested in previous reviews and meta-ana-
lyses[1,6,17,23-25,32,106]. rTMS has become a promising 
therapeutic tool for a variety of neurological and 
psychiatric diseases[107]. Different types of NP respond to 
rTMS, and this is producing a fast growth in researchers 
interested in rTMS for clinical purposes[6,26,108-110]. 
Unfortunately at the current time in the lack of large 
studies, only careful recommendations of rTMS can be 
suggested[1,6]. The efficacy of a single HF-rTMS session 
persists for some days, and it could extend with the 
repetition of sessions[1]. Moreover, the best stimulation 
settings may be yet to determined. 
Studies including neurophysiological evaluation of 
the effects of the cortex TMS in other brain regions 
through the use of imaging and electrophysiologic 
techniques (such as electroencephalography, magne-
toencephalography, MRI navigated TMS) could add 
value at the understanding of the mechanism of action 
of this technique[111]. New TMS machines have allowed 
the administration of pulses more focally and at higher 
frequencies. Moreover, frameless stereotactic systems, 
have been developed, permitting the identification 
of specific location in the desired brain target and 
the precise and comparable placing of the coil during 
different TMS sessions[112-114]. 
In future, therapeutic studies need to define the 
correct utilization of rTMS in the clinical practice for 
chronic pain, above all if the long-term effect exists. 
Moreover, studies of rTMS in other diseases associated 
with chronic pain, such as osteoarthritis, bladder pain 
syndrome and post-stroke pain, could be of interest. 
Finally, if rTMS becomes a proven method for the 
treatment of chronic pain, the development of a home-
based rTMS system will be necessary[115].
Active research in pain is still taking place and has 
the potential to provide useful data (31 open studies 
on TMS and pain on https://clinicaltrials.gov). Based 
on this new research, novel therapeutic guidelines 
may be established in future. Apart from its potential 
clinical role, rTMS is a valuable probe of brain function 
that can be used to investigate the neural circuitry. This 
additional knowledge might help in the development 
of new treatments. rTMS is non-invasive and can be 
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applied to any patient with drug-resistant NP who could 
be aspirant for the insertion of a cortical stimulator. In 
addition, further studies using maintenance sessions 
of rTMS and evaluating the multiple features of chronic 
pain are needed to give a more solid basis for its clinical 
applications.
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